Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
about
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
P2860
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Chemotherapeutic intensity and ...... edish Lymphoma Registry study.
@en
type
label
Chemotherapeutic intensity and ...... edish Lymphoma Registry study.
@en
prefLabel
Chemotherapeutic intensity and ...... edish Lymphoma Registry study.
@en
P2093
P2860
P356
P1476
Chemotherapeutic intensity and ...... edish Lymphoma Registry study.
@en
P2093
Björn Engelbrekt Wahlin
Christopher M Melén
Gunilla Enblad
Henna Riikka Junlén
Kristina Sonnevi
Mats Jerkeman
P2860
P304
P356
10.1111/BJH.14399
P407
P577
2016-10-28T00:00:00Z